SCHEMBL10680434

SCHEMBL10680434

CCOC(=O)C1CN(CC(=O)Nc2c(Cl)cccc2Cl)CCN1CCCC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.58
MEN1 O00255 5/20 0.58
HTR2A P28223 4/20 0.58
ADRA1A P35348 4/20 0.58
HRH1 P35367 4/20 0.58
DRD3 P35462 4/20 0.58
OPRK1 P41145 4/20 0.58
SLC6A3 Q01959 4/20 0.58
LMNA P02545 4/20 0.58
ADORA3 P0DMS8 3/20 0.58
DRD2 P14416 3/20 0.58
OPRD1 P41143 3/20 0.58
SLC29A1 Q99808 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 2/20 0.58
USP2 O75604 2/20 0.58
MLNR O43193 1/20 0.58
NR1I2 O75469 1/20 0.58
CYP1A2 P05177 1/20 0.58
PGR P06401 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10676097 0.92 ADRA1A (0.70) KMT2AMEN1HTR2AADRA1AHRH1
SCHEMBL10681498 0.89 SLC29A1 (0.60) KMT2AMEN1HTR2AADRA1AHRH1
Mioflazine SCHEMBL124029 0.88 SLC29A1 (0.70) KMT2AMEN1HTR2AADRA1AHRH1
Mioflazine SCHEMBL8675598 0.87 SLC29A1 (0.69) KMT2AMEN1HTR2AADRA1AHRH1
Mioflazine SCHEMBL119416 0.86 SLC29A1 (0.68) KMT2AMEN1HTR2AADRA1AHRH1
Mioflazine SCHEMBL611300 0.86 SLC29A1 (0.68) KMT2AMEN1HTR2AADRA1AHRH1
SCHEMBL10683725 0.82 ADRA1A (0.76) KMT2AMEN1HTR2AADRA1AHRH1
SCHEMBL10677558 0.82 HTR2A (0.48) KMT2AMEN1HTR2AADRA1AHRH1
SCHEMBL10676335 0.82 MEN1 (0.67) KMT2AMEN1HTR2AADRA1AHRH1
SCHEMBL10676648 0.81 ADRA1A (0.73) KMT2AMEN1HTR2AADRA1AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP disclosed
EP-0068544-A2 Novel N-aryl-piperazinealkanamides JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-05 EP disclosed